Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Christopher Jones

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Lung|March 24, 2025
Dasatinib-Associated Chylothorax: A Review of Cases Reported to the FDA Adverse Event Reporting System and the Published LiteratureDavid A Kaland, Graça M Dores, Afrouz Nayernama, et al.
Pediatric Blood & Cancer|December 26, 2025
Postmarketing Cases of Erdafitinib-Associated Skeletal Growth Toxicity Events in Pediatric PatientsMichelle Nadeau Nguyen, Graça M Dores, Afrouz Nayernama, et al.
Contraception|September 5, 2017
Etonogestrel implant migration to the vasculature, chest wall, and distant body sites: cases from a pharmacovigilance databaseSarah Kang, Ali Niak, Neha Gada, et al.
Leukemia & Lymphoma|May 25, 2018
Ibrutinib-associated ventricular arrhythmia in the FDA Adverse Event Reporting SystemConnie Cheng, Daniel Woronow, Afrouz Nayernama, et al.
Journal of Chemotherapy (Florence, Italy)|October 6, 2023
Varicella zoster virus reactivation reported with isatuximab useMichelle Nadeau Nguyen, Graça M Dores, Afrouz Nayernama, et al.
American Journal of Hematology|January 5, 2022
Hemolytic anemia following alectinib reported to the U.S. Food and Drug Administration Adverse Event Reporting SystemGraça M Dores, Afrouz Nayernama, Connie Cheng, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 4, 2018
Wound healing complications with lenvatinib identified in a pharmacovigilance databaseConnie Cheng, Afrouz Nayernama, S Christopher Jones, et al.
American Journal of Hematology|August 18, 2017
Ibrutinib-associated Pneumocystis jirovecii pneumoniaRegina Lee, Afrouz Nayernama, S Christopher Jones, et al.
Drug Safety|July 11, 2020
An Evaluation of Postmarketing Reports of Serious Idiosyncratic Liver Injury Associated with Ulipristal Acetate for the Treatment of Uterine FibroidsSarah Kang, Allen Brinker, S Christopher Jones, et al.
Pediatric Hematology and Oncology|August 28, 2024
Hepatic veno-occlusive disease with asparaginase products: a review of cases reported to the FDA adverse event reporting system and published in the literatureConnie Cheng, Graça M Dores, Afrouz Nayernama, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Lung|March 24, 2025
Dasatinib-Associated Chylothorax: A Review of Cases Reported to the FDA Adverse Event Reporting System and the Published LiteratureDavid A Kaland, Graça M Dores, Afrouz Nayernama, et al.
Pediatric Blood & Cancer|December 26, 2025
Postmarketing Cases of Erdafitinib-Associated Skeletal Growth Toxicity Events in Pediatric PatientsMichelle Nadeau Nguyen, Graça M Dores, Afrouz Nayernama, et al.
Contraception|September 5, 2017
Etonogestrel implant migration to the vasculature, chest wall, and distant body sites: cases from a pharmacovigilance databaseSarah Kang, Ali Niak, Neha Gada, et al.
Leukemia & Lymphoma|May 25, 2018
Ibrutinib-associated ventricular arrhythmia in the FDA Adverse Event Reporting SystemConnie Cheng, Daniel Woronow, Afrouz Nayernama, et al.
Journal of Chemotherapy (Florence, Italy)|October 6, 2023
Varicella zoster virus reactivation reported with isatuximab useMichelle Nadeau Nguyen, Graça M Dores, Afrouz Nayernama, et al.
American Journal of Hematology|January 5, 2022
Hemolytic anemia following alectinib reported to the U.S. Food and Drug Administration Adverse Event Reporting SystemGraça M Dores, Afrouz Nayernama, Connie Cheng, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 4, 2018
Wound healing complications with lenvatinib identified in a pharmacovigilance databaseConnie Cheng, Afrouz Nayernama, S Christopher Jones, et al.
American Journal of Hematology|August 18, 2017
Ibrutinib-associated Pneumocystis jirovecii pneumoniaRegina Lee, Afrouz Nayernama, S Christopher Jones, et al.
Drug Safety|July 11, 2020
An Evaluation of Postmarketing Reports of Serious Idiosyncratic Liver Injury Associated with Ulipristal Acetate for the Treatment of Uterine FibroidsSarah Kang, Allen Brinker, S Christopher Jones, et al.
Pediatric Hematology and Oncology|August 28, 2024
Hepatic veno-occlusive disease with asparaginase products: a review of cases reported to the FDA adverse event reporting system and published in the literatureConnie Cheng, Graça M Dores, Afrouz Nayernama, et al.
Pageof 4